OOIR: Observatory of International Research

Papers

(The TQCC of Cost Effectiveness and Resource Allocation is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Cost per DALY averted in low, middle- and high-income countries: evidence from the global burden of disease study to estimate the cost-effectiveness thresholds	36
Successes and challenges of China’s health care reform: a four-decade perspective spanning 1985—2023	24
Economic burden of cardiovascular diseases before and after Iran’s health transformation plan: evidence from a referral hospital of Iran	21
What makes inequality in the area of dental and oral health in developing countries? A scoping review	21
Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making	20
Strategies for reducing out of pocket payments in the health system: a scoping review	19
Examination on level of scale efficiency in public hospitals in Tanzania	18
Health technology assessment in sub-Saharan Africa: a descriptive analysis and narrative synthesis	18
First-line pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer: a United States-based cost-effectiveness analysis	16
Level and determinants of county health system technical efficiency in Kenya: two stage data envelopment analysis	16
Cost-effectiveness analysis of text messaging to support health advice for smoking cessation	15
Health technology assessment of medical devices: current landscape, challenges, and a way forward	15
Household catastrophic health expenditure and its effective factors: a case of Iran	15
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma	14
Market access and value-based pricing of digital health applications in Germany	14
What are economic costs and when should they be used in health economic studies?	13
Cost-effectiveness analysis of oral nutritional supplements with nutritional counselling in head and neck cancer patients undergoing radiotherapy	12
Hospital efficiency measurement in the west of Iran: data envelopment analysis and econometric approach	12
Generalised cost-effectiveness analysis of 159 health interventions for the Ethiopian essential health service package	12
Predicting positive organizational behavior based on structural and psychological empowerment among nurses	12
Methodological challenges surrounding QALY estimation for paediatric economic evaluation	11
Factors affecting the technical efficiency of rural primary health care centers in Hamadan, Iran: data envelopment analysis and Tobit regression	11
Cost-effectiveness of using amyloid positron emission tomography in individuals with mild cognitive impairment	11
Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings	10
Assessing the performance of health technology assessment (HTA) agencies: developing a multi-country, multi-stakeholder, and multi-dimensional framework to explore mechanisms of impact	10

Comparison of cost effectiveness between video-assisted thoracoscopic surgery (vats) and open lobectomy: a retrospective study	10
Cost effectiveness of outpatient lumbar discectomy	10
Cost-effectiveness of pharmacological therapies for people with Alzheimer’s disease and other dementias: a systematic review and meta-analysis	10
Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China	9
Can integrated care improve the efficiency of hospitals? Research based on 200 Hospitals in China	9
Selecting the most suitable organizational structure for hospitals: an integrated fuzzy FUCOM-MARCOS method	9
Cost transferability problems in economic evaluation as a framework for an European health care and social costs database	9
The origin of cost–benefit analysis: a comparative view of France and the United States	9
Medical expenditure for lung cancer in China: a multicenter, hospital-based retrospective survey	9
A budget impact analysis of substituting sitagliptin with liraglutide in type 2 diabetes from a private health insurance perspective in Egypt	8
Cost-effectiveness analysis of sorafenib, lenvatinib, atezolizumab plus bevacizumab and sintilimab plus bevacizumab for the treatment of advanced hepatocellular carcinoma in China	8
Neural networks and hospital length of stay: an application to support healthcare management with national benchmarks and thresholds	8
The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong	8
Reconciling ACEA and MCDA: is there a way forward for measuring cost-effectiveness in the U.S. healthcare setting?	8
Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong	8
Cost-effectiveness of a novel smartphone application to mobilize first responders after witnessed OHCA in Belgium	8
Comparison of the healthcare system of Chile and Brazil: strengths, inefficiencies, and expenditures	8
The influence of medical insurance and social security cards on the floating population's settlement intention	8
A systematic review of the economic evaluations of Enzyme Replacement Therapy in Lysosomal Storage Diseases	8
Cost-effectiveness analysis of adding durvalumab to chemotherapy as first-line treatment for advanced biliary tract cancer based on the TOPAZ-1 trial	8
Patients’ preferences for antiretroviral therapy service provision: a systematic review	7
Cost-effectiveness of a care manager collaborative care programme for patients with depression in primary care: 12-month economic evaluation of a pragmatic randomised controlled trial	7
Total productivity change of Health Centers in Greece in 2016–2018: a Malmquist index data envelopment analysis application for the primary health system of Greece	7
Household preferences and willingness to pay for health insurance in Kampala City: a discrete choice experiment	7
A systemmatic literature review on indirect costs of women with breast cancer	7
Essential emergency and critical care as a health system response to critical illness and the COVID19 pandemic: what does it cost?	7
Changes in productivity in healthcare services in the Kingdom of Saudi Arabia	7
A qualitative study on patient-centered care and perceptions of nurses regarding primary healthcare facilities in Nigeria	6
Cost–benefit analysis of kidney transplant in patients with chronic kidney disease: a case study in Iran	6
Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives	6
Impact of changes in the methodology of external price referencing on medicine prices: discrete-event simulation	6
Analysis of the gap in PCR monitoring availability for patients with chronic myeloid leukemia in 60 low- and middle-income countries	6
Heterogeneity in health funding and disparities in health outcome: a comparison between high focus and non-high focus states in India	6
Supporting a review of the benefits package of the National Health Insurance Scheme in Ghana	6
Predictors of loss due to pharmaceutical fraud: evidence from the U.S.	6
The population-level economic burden of liver cancer in China, 2019–2030: prevalence-based estimations from a societal perspective	6
Cost-effectiveness of integrated disease management for high risk, exacerbation prone, patients with chronic obstructive pulmonary disease in a primary care setting	6
Tuberculosis prevention, diagnosis, and treatment financial profile during 2006–2021: PART A	6
Impact of quality certification of multidisciplinary head and neck tumor centers	6
Cost-effectiveness analysis for SilAtro-5-90 adjuvant treatment in the management of recurrent tonsillitis, compared with usual care only	6
Generic drug crisis in Japan and changes leading to the collapse of universal health insurance established in 1961: the case of Kobayashi Kako Co. Ltd.	6
A systematic review of the budget impact analyses for antitumor drugs of lung cancer	6
How a thrombectomy service can reduce hospital deficit: a cost-effectiveness study	6
Cost-effectiveness of surgical treatment of thumb carpometacarpal joint arthritis: a value of information study	5
The health care sector in the economies of the European Union: an overview using an input–output framework	5
Cost-effectiveness of a reactive oral cholera immunization campaign using Shanchol™ in Malawi	5
Exploring physicians and patients’ perspectives for current interventions on thyroid nodules using a MCDA method	5
Overview of the main methods used for estimating catastrophic health expenditure	5
Clinical and economic benefits of image-guided system in functional endoscopicsinus surgery: a retrospective chart review study in China	5
A systematic literature review on direct and indirect costs of triple-negative breast cancer	5

Risk factors associated with postoperative complications after liver cancer resection surgery in western China	5
Recommendations to improve insurance coverage for physiotherapy services in Iran: a multi criteria decision-making approach	5
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine compared with 23-valent pneumococcal polysaccharide vaccine among adults in a Norwegian setting	5
The potential of real-time analytics to improve care for mechanically ventilated patients in the intensive care unit: an early economic evaluation	5
Title: the impact of a pilot integrated care model on the quality and costs of inpatient care among chinese elderly: a difference-in-difference analysis of repeated cross-sectional data	5
Investing in midwifery for sustainable development goals in low- and middle-income countries: a cost-benefit analysis	5
Cost analysis of the management of end-stage renal disease patients in Abuja, Nigeria	5
The influence of cross-regional medical treatment on total medical expenses, medical insurance payments, and out-of-pocket expenses of patients with malignant tumors in Chinese low-income areas	5
Treatment pathways and associated costs of metastatic colorectal cancer in Greece	5
Cost-effectiveness of paclitaxel, doxorubicin, cyclophosphamide and trastuzumab versus docetaxel, cisplatin and trastuzumab in new adjuvant therapy of breast cancer in china	5